|
Volumn 22, Issue 9, 2016, Pages 987-990
|
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOUBLE STRANDED DNA;
GENOMIC DNA;
GUIDE RNA;
HEMOGLOBIN BETA CHAIN;
HEMOGLOBIN F;
HEMOGLOBIN GAMMA CHAIN;
HEMOGLOBIN SUBUNIT GAMMA 1;
HEMOGLOBIN SUBUNIT GAMMA 2;
LENTIVIRUS VECTOR;
MESSENGER RNA;
UNCLASSIFIED DRUG;
HEMOGLOBIN A;
ARTICLE;
BETA THALASSEMIA;
CASE REPORT;
COMPARATIVE STUDY;
CONTROLLED STUDY;
CRISPR CAS SYSTEM;
CRISPR CAS9 SYSTEM;
DNA END JOINING REPAIR;
DNA MODIFICATION;
DOUBLE STRANDED DNA BREAK;
ERYTHROCYTE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE EXPRESSION;
GENE MUTATION;
GENE SEQUENCE;
GENE TARGETING;
HEMATOPOIETIC STEM CELL;
HUMAN;
HUMAN CELL;
HUMAN GENOME;
IN VITRO STUDY;
INTERNAL RIBOSOME ENTRY SITE;
MOLECULAR PATHOLOGY;
PRIORITY JOURNAL;
PROMOTER REGION;
PROTEIN ANALYSIS;
REGULATOR GENE;
RNA SEQUENCE;
SICKLE CELL ANEMIA;
THERAPY EFFECT;
ANEMIA, SICKLE CELL;
BETA-THALASSEMIA;
ERYTHROID PRECURSOR CELL;
GENE EDITING;
GENETICS;
METABOLISM;
MUTATION;
PROCEDURES;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SITE DIRECTED MUTAGENESIS;
ANEMIA, SICKLE CELL;
BETA-GLOBINS;
BETA-THALASSEMIA;
CRISPR-CAS SYSTEMS;
ERYTHROID PRECURSOR CELLS;
FETAL HEMOGLOBIN;
GAMMA-GLOBINS;
GENE EDITING;
HEMOGLOBIN A;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
MUTAGENESIS, SITE-DIRECTED;
MUTATION;
PROMOTER REGIONS, GENETIC;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
|
EID: 84982181938
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.4170 Document Type: Article |
Times cited : (272)
|
References (21)
|